HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Christodoulides, N. Articles by McDevitt, J. T. Search for Related Content PubMed PubMed Citation Articles by Christodoulides, N. Articles by McDevitt, J. T. Related Collections Point-of-Care Testing Automation and Analytical Techniques

Toward the Development of a Lab-on-a-Chip Dual-Function Leukocyte and C-Reactive Protein Analysis Method for the Assessment of Inflammation and Cardiac Risk

¹ Department of Chemistry & Biochemistry, and the² Center for Nano and Molecular Science and Technology,³ Texas Materials Institute, The University of Texas at Austin, Austin, TX

^aaddress correspondence to this author at: Department of Chemistry & Biochemistry, Texas Materials Institute, The University of Texas at Austin, Austin, TX 78735; fax 512-232-7052, e-mail mcdevitt@mail.utexas.edu

The first 300 words of the full text of this article appear below.

Inflammation has been identified as the underlying cause of atherosclerosis, a condition associated with the deposition of lipids in the lining of arteries, which progressively leads to acute myocardial infraction (AMI) or heart attack. Serum concentrations of markers of inflammation, including C-reactive protein (CRP), and the leukocyte count are powerful predictors for the development of coronary heart disease (1)(2)(3)(4)(5)(6)(7). In addition, AMI patients with increased CRP concentrations or leukocyte counts are at higher risk of mortality and recurrent AMI (8)(9)(10)(11)(12). The combination of these 2 biomarkers provides additive and powerful diagnostic information. In fact, people with both high leukocyte counts and high CRP concentrations exhibit a 7-fold higher risk for heart disease (7).

Although tests targeting CRP concentrations and leukocyte counts are widely available in clinical settings, they are performed separately on different instruments. Consequently, these tests require large sample volumes, additional sample preparation steps, and longer assay times. In addition, the clinical instruments and methodologies currently used to perform these tests are not suitable for point-of-care testing, such as in a doctor’s office and in the (more relevant to a heart attack setting) emergency room or ambulance. Clearly, the diagnostic and prognostic value of these biomarkers would be increased if these 2 tests could be performed concurrently on the same instrument, in a convenient, accurate, and highly accessible manner.

Previously we described studies of the design, fabrication, and testing of lab-on-a-chip (LOC) structures composed of chemically sensitized beads that are populated into etched silicon wafers with integrated fluid-handling and optical detection capabilities (13)(14)(15)(16)(17)(18)(19). These miniaturized systems have been used . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				Edited on behalf of the National Institute of Biom, C. P. Price, and L. J. Kricka Improving Healthcare Accessibility through Point-of-Care Technologies Clin. Chem., September 1, 2007; 53(9): 1665 - 1675. [Abstract] [Full Text] [PDF]